382 related articles for article (PubMed ID: 28743090)
1. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery.
Hang C; Zou Y; Zhong Y; Zhong Z; Meng F
Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090
[TBL] [Abstract][Full Text] [Related]
2. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
3. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
4. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
[TBL] [Abstract][Full Text] [Related]
5. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.
Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D
Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer.
Liu D; Zhang Q; Wang J; Fan L; Zhu W; Cai D
Pharmazie; 2019 Feb; 74(2):83-90. PubMed ID: 30782256
[TBL] [Abstract][Full Text] [Related]
9. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
Liang K; Ng S; Lee F; Lim J; Chung JE; Lee SS; Kurisawa M
Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145
[TBL] [Abstract][Full Text] [Related]
10. Phytosterol-loaded CD44 receptor-targeted PEGylated nano-hybrid phyto-liposomes for synergistic chemotherapy.
Gautam M; Thapa RK; Gupta B; Soe ZC; Ou W; Poudel K; Jin SG; Choi HG; Yong CS; Kim JO
Expert Opin Drug Deliv; 2020 Mar; 17(3):423-434. PubMed ID: 32028805
[No Abstract] [Full Text] [Related]
11. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
[TBL] [Abstract][Full Text] [Related]
12. Endosomal pH-Responsive Fe-Based Hyaluronate Nanoparticles for Doxorubicin Delivery.
Bae Y; Kim Y; Lee ES
Molecules; 2021 Jun; 26(12):. PubMed ID: 34200716
[TBL] [Abstract][Full Text] [Related]
13. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
14. Multi-layered cellulose nanocrystal system for CD44 receptor-positive tumor-targeted anticancer drug delivery.
Seo JH; Lee SY; Hwang C; Yang M; Lee J; Lee SH; Cho HJ
Int J Biol Macromol; 2020 Nov; 162():798-809. PubMed ID: 32585268
[TBL] [Abstract][Full Text] [Related]
15. The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin.
Wang J; Ma W; Guo Q; Li Y; Hu Z; Zhu Z; Wang X; Zhao Y; Chai X; Tu P
Int J Nanomedicine; 2016; 11():5851-5870. PubMed ID: 27853369
[TBL] [Abstract][Full Text] [Related]
16. Azo modified hyaluronic acid based nanocapsules: CD44 targeted, UV-responsive decomposition and drug release in liver cancer cells.
Chen Q; Li X; Xie Y; Hu W; Cheng Z; Zhong H; Zhu H
Carbohydr Polym; 2021 Sep; 267():118152. PubMed ID: 34119127
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
19. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid nanogels with enzyme-sensitive cross-linking group for drug delivery.
Yang C; Wang X; Yao X; Zhang Y; Wu W; Jiang X
J Control Release; 2015 May; 205():206-17. PubMed ID: 25665867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
